Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore - Wikidata - wikimedia - TriplyDB

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

http://www.wikidata.org/entity/Q34327908

about

Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion Injury Mitochondrial Dysfunction in Alzheimer's Disease and the Rationale for Bioenergetics Based Therapies Regulation of mitochondrial functions by protein phosphorylation and dephosphorylation Mitochondrial ROMK channel is a molecular component of mitoK(ATP)Role of the MPTP in conditioning the heart - translatability and mechanism The GSK-3 family as therapeutic target for myocardial diseases From ATP to PTP and Back: A Dual Function for the Mitochondrial ATP Synthase The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.ROG1 encodes a monoacylglycerol lipase in Saccharomyces cerevisiae.Autophagy, a process within reperfusion injury: an update Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model Selective blockade of protein kinase B protects the rat and human myocardium against ischaemic injury Estrogen deficiency decreases ischemic tolerance in the aged rat heart: Roles of PKCdelta, PKCepsilon, Akt, and GSK3beta Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress Mitochondrial adenine nucleotide transport and cardioprotection Isoflurane postconditioning induces neuroprotection via Akt activation and attenuation of increased mitochondrial membrane permeability Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3β in human neuron-like cells.Glycolytic oscillations in isolated rabbit ventricular myocytes.Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells Translocation of glycogen synthase kinase-3β (GSK-3β), a trigger of permeability transition, is kinase activity-dependent and mediated by interaction with voltage-dependent anion channel 2 (VDAC2).Survival and cardioprotective benefits of long-term blueberry enriched diet in dilated cardiomyopathy following myocardial infarction in rats.3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium.Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation.Mg2+ protects adult beating cardiomyocytes against ischaemia Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function.Blueberry-enriched diet protects rat heart from ischemic damage.RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.Cardioprotection leads to novel changes in the mitochondrial proteome.Neuroprotection provided by isoflurane pre-conditioning and post-conditioning Protein Kinase Signaling at the Crossroads of Myocyte Life and Death in Ischemic Heart Disease.Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy.Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1.

P2860

Q24312702-6BAB1FEA-D303-4655-B4B8-5CABA6DD25C5 Q24336120-8AF61300-49AB-4DC5-AE8B-FEE969F4F9B2 Q26744639-1739B158-57CC-4622-812C-3FC9F171C183 Q26750081-22725E43-EFF3-482F-ADAF-467E8150DBB8 Q26752880-3EE42E87-6B73-4B75-B0ED-C4D39F36D52A Q26781995-87951F64-516D-4965-B6AF-A5268B99BA55 Q26830560-689EFEDA-6A3C-4E1C-948B-E860E2F2BF35 Q26861134-B6AFCDCB-E20A-4880-A6F0-57FCA90454BF Q27004110-E8EB4BBF-981A-4F5F-9B2D-9734ADF2F20C Q27012559-B40C2C1D-B756-4213-BA42-1BDC3EC381A9 Q27350484-D3A05562-9EAB-4C99-B59A-C099A2DC050A Q27938916-051E83EE-F959-4805-B4F2-F00639902F53 Q28086932-A755E070-D364-4DFB-9FB2-FED6F7AC621A Q28285463-0DEE9B26-CF3C-4772-B792-F7C01507D575 Q28397090-D094FDA1-87D6-4DC1-858D-36521F8F488A Q28397180-56F77107-0E4A-4A0C-93F8-D71DED86404B Q28546468-68868637-2BF0-4422-B8CC-D1EF32AC3737 Q28567327-1C02CBE5-3ADD-4BB7-AD53-CCC0DC3A37DC Q28573241-D68202BE-81E2-4ACF-A289-AB961814961D Q28577217-5F4EF03E-482A-4BE0-AFC0-F10E49B9D6A4 Q28660732-39A5A391-397F-4B43-B216-42E274BB1B40 Q28740277-42D2056D-DEC6-44B5-BB6B-A07F5C946B16 Q30423236-42FAF340-622F-4A14-BFF8-7482ECA6A446 Q30427390-CB688665-ECAD-46FB-916B-62795284CF0B Q30485129-A17DE079-4AE8-4B02-957D-D30A6CE21BC9 Q30496731-9DD6F3F4-D7C2-4A0B-BE4F-2A6FBA1C9536 Q30593479-25D0DB01-FE33-442A-9596-CAD44800F3DB Q30914034-1922B8D5-4DDD-4A0B-A832-E9C7336384C3 Q33262306-75F0D5CB-E316-4351-B675-7E03B2E2BE73 Q33276827-9BF28501-365E-44F9-A46D-ED474B7B280D Q33311706-1BE836A9-CE27-4CE6-8C0F-D818F610479F Q33344170-B1165E5E-08C2-4B35-A620-1EDA831DC348 Q33470259-E28A3C99-CE48-4F05-BC75-FC3356263D90 Q33559727-2B58F687-F1A8-44A9-885F-FB0BBF433884 Q33589244-D152D742-6108-4C92-B114-11B3234B88E3 Q33594536-801F5A87-7F26-4C24-8E63-6FD9D93D3D37 Q33604010-B14DC5A3-CCC9-4463-A835-B4956229A458 Q33640002-7428FDB4-6A74-40E1-8A13-6A8022A1FF9A Q33691265-4B387F40-2B67-44F7-9343-F3479D700E4C Q33707120-48036E0B-6483-4A11-9AC4-F2B34682B540

P2860

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

http://www.wikidata.org/entity/Q34327908

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Glycogen synthase kinase-3beta ...... l permeability transition pore

@ast

Glycogen synthase kinase-3beta ...... l permeability transition pore

@en

Glycogen synthase kinase-3beta ...... l permeability transition pore

@nl

type

label

Glycogen synthase kinase-3beta ...... l permeability transition pore

@ast

Glycogen synthase kinase-3beta ...... l permeability transition pore

@en

Glycogen synthase kinase-3beta ...... l permeability transition pore

@nl

prefLabel

Glycogen synthase kinase-3beta ...... l permeability transition pore

@ast

Glycogen synthase kinase-3beta ...... l permeability transition pore

@en

Glycogen synthase kinase-3beta ...... l permeability transition pore

@nl

P1433

Q34327908-2C1F26EC-23AE-4ACB-B4E5-6E3794F4B755

P1476

Q34327908-FD835A3A-56C9-4BAB-8955-E4962BAE1406

P2093

Q34327908-04AE9E41-30C1-41DA-BDE3-61BC93E4B3AA

Q34327908-07BE654A-4D77-407B-868D-EBC2DF87C778

Q34327908-10195BB2-117A-4641-865A-E0469C96DD53

Q34327908-5EAE1C65-0EDA-4DBE-89E5-AFDE3B296B52

Q34327908-898D2B61-E764-4FA3-8FDF-A5C98D3598EF

Q34327908-8BBCF7E6-5F2E-4FD7-B026-4857B26FFB7B

Q34327908-9E4F5C7E-22CF-4FC4-901E-66B8C0B222AE

Q34327908-A02F5126-82E0-493C-B532-4A28BBCE2031

Q34327908-AE5C9E76-5368-4D91-BDCF-A5896A34B57E

Q34327908-B6676E0E-F836-474B-A816-09C40D679BC8

P2860

Q34327908-02AE406D-7B9D-49F0-A54B-BF12DC8E1325

Q34327908-047C771C-6268-45F9-8AB7-7558AFB11FA9

Q34327908-1193E428-ED08-4A9A-9C9E-8EA6C3935908

Q34327908-15050014-B9C3-44F3-BB75-DAED7A74B037

Q34327908-196325C9-14B4-4D89-917C-D36261DD5FD1

Q34327908-233BE95F-ED29-491D-92B9-1A0ACE848A22

Q34327908-2AF032E7-5AE4-40C1-963E-E8CCCE604586

Q34327908-30FE0A7C-6FFA-4487-A425-EA603041D092

Q34327908-333BEDAE-AED8-4B9D-BF65-E858434B11AC

Q34327908-38371973-5974-42EF-9C39-D137A39F9537

P304

Q34327908-86F21093-EADA-43F3-8B76-4AD54DBCF9C0

P31

Q34327908-AF0361A4-7240-427C-87B7-4957EEDF755D

P356

Q34327908-55A54D97-50C9-4236-942E-3186C9D5EBC3

P407

Q34327908-FF16D67B-B1AD-42A1-8A9E-4F24AA6D80C0

P433

Q34327908-F11A0261-B1F5-4936-A118-A2E843081471

P478

Q34327908-99227B12-47E5-4CDE-82AE-772F41EB57DD

P577

Q34327908-245985AC-E515-45AD-B88B-4A09447242DA

P698

Q34327908-3BA0E6D4-B78D-4477-97D5-FF1330F34F94

P921

Q34327908-B1732742-19D7-415C-B84B-C1081E878E18

P932

Q34327908-C372C3ED-6992-4622-A137-12A60AB7AE77

P356

P1433

Journal of Clinical Investigation

P1476

Glycogen synthase kinase-3beta ...... l permeability transition pore

@en

P2093

Bruce D Ziman

http://www.w3.org/2001/XMLSchema#string

Christopher L Antos

http://www.w3.org/2001/XMLSchema#string

Dmitry B Zorov

http://www.w3.org/2001/XMLSchema#string

Eric N Olson

http://www.w3.org/2001/XMLSchema#string

Kenneth W Fishbein

http://www.w3.org/2001/XMLSchema#string

Kirsti Ytrehus

http://www.w3.org/2001/XMLSchema#string

Magdalena Juhaszova

http://www.w3.org/2001/XMLSchema#string

Qin Fu

http://www.w3.org/2001/XMLSchema#string

Salvatore Pepe

http://www.w3.org/2001/XMLSchema#string

Steven J Sollott

http://www.w3.org/2001/XMLSchema#string

P2860

Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death

Radicals r'aging.

BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003

Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation

Glycogen synthase kinase-3: functions in oncogenesis and development

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

ATP-sensitive K+ channel in the mitochondrial inner membrane

P304

1535-1549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI19906

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15173880

http://www.w3.org/2001/XMLSchema#string

P921

P932

419483

http://www.w3.org/2001/XMLSchema#string